According to the CDC, at least 95% of people have PFAS in their blood

Per and polyfluoroalkyl substances (PFAS) are a class of approximately 12,000 human-made substances that are ubiquitous in both environmental and biological matrices. PFAS are bioaccumulative, persistent and have been linked to health effects at very low levels. Recently, the EPA proposed legally enforceable levels for PFAS in drinking water. If passed, the new standards will require public water systems to test for PFAS, likely increasing patient concerns around exposure and associated health effects. As the science continues to develop, providing clinical guidance to patients will require shared, informed decision-making.

This 60-minute webinar will provide vital information and best practices regarding PFAS and clinical care, followed by a live Q&A with toxicology and medical experts. It will prepare clinicians to discuss patient concerns and steps to reduce exposure, and identify appropriate clinical follow-up for patients with varying levels of PFAS.

PFAS: Information and Guidance for Health Care Providers

Colorado health care providers (MD, DO, APP, RN, etc.) interested in the impact of PFAS on health outcomes

Wednesday, April 5, 5:00 PM MT OR
Thursday, April 6, 12:00 PM MT


CME for this webinar has been applied for and is pending approval.
Participants are expected to earn one credit.


In partnership with: